The Access Brief No. 7: FDA Fees, Device Alerts & Canada Trade Risks
Issue No. 7 · Week of September 28, 2026 Two FDA field actions landed the…
Deryll NewmanSeptember 28, 2026
The Access Brief No. 6: VA Market Access, FDA Pathways & Supply Chain Rules
Issue No. 6 · Week of September 21, 2026 The biggest signal for foreign manufacturers…
Deryll NewmanSeptember 21, 2026
The Access Brief No. 5: Device Recalls, Cybersecurity & Canada Tariff Relief
Issue No. 5 · Week of September 14, 2026 This week's clearest signal was how…
Dawa MedicalSeptember 14, 2026
The Access Brief No. 4: FDA Recalls, Supply Chain Risks & Import Updates
Issue No. 4 · Week of September 7, 2026 This week was less about any…
Dawa MedicalSeptember 7, 2026
The Access Brief No. 3: Device Recalls, Supplier Traceability & Canada Tariffs
Issue No. 3 · Week of August 31, 2026 Health Canada had a busy week…
Dawa MedicalAugust 31, 2026
The Access Brief No. 2: U.S.-Canada Tariffs & FDA Leadership Changes
Issue No. 2 · Week of August 24, 2026 This week brought real movement on…
Dawa MedicalAugust 24, 2026
Simplifying the World’s Largest Medtech Market
Don’t miss part three of our Simplifying the World’s Largest Medtech Market webinar series, where…
Dawa MedicalSeptember 26, 2022
In the vast majority of cases, foreign manufacturers find out about an initial importer upon…
Dawa MedicalMay 26, 2022
In the vast majority of cases, foreign manufacturers find out about an initial importer upon…
Dawa MedicalJuly 19, 2021
